115 proteins identified that would allow designing new generation anti-cancer drugs

Researchers have identified 115 proteins in silico that could be highly relevant to treat colon-rectal cancer, since they would make it possible to define the strategy to design new generation anti-cancer drugs. During the last years, it has been shown that drugs are not as selective as it was thought, and that they actually have an affinity for multiple biological targets. For this reason it is important to develop multi-target drugs, able to attack several targets simultaneously.